{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:06:06Z","timestamp":1791893166868,"version":"4.3.4"},"reference-count":45,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T00:00:00Z","timestamp":1738022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The aims of this study were to assess the impact of smoking on cervical histopathology in women with high-risk HPV types 16 and 18 (the most common types) utilizing comprehensive clinical data and to conduct a risk analysis based on smoking pack-years. Materials and Methods: Between 2022 and 2024, 1048 high-risk HPV-positive women aged 25 to 65 years were categorized into two groups: smokers and non-smokers. Data acquired from a histopathological examination of samples collected during a colposcopic evaluation of these women were compared individually regarding clinical and demographic factors, specifically age, gravida, parity, and alcohol consumption. Subsequently, the impact of prolonged and excessive smoking on histopathological cellular changes was assessed in women with the same characteristics. A case\u2013control study was performed on 312 smokers and 312 non-smokers following mutual matching. Results: The women were matched one-to-one regarding gravida, parity, and alcohol consumption. Subsequently, they were paired within a \u00b12-year age range. The mean age of the smoker group was 47.1 \u00b1 8.8, while that of the non-smoker group was 47.2 \u00b1 8.5 (p: 0.904). In all cases of high-risk HPV positivity, the rate of normal cervical cytological results was 14% in women who smoked and 29% in women who did not smoke. The LGSIL, HGSIL, ASC-H, and AGC-NOS rates were elevated in the smoker group, and a statistically significant difference was observed between the two groups in terms of abnormal cervical cytological results (p &lt; 0.001). After a colposcopic biopsy, the smoker group exhibited higher rates of HGSILs, LGSILs, AGC-NOS, and CIS pathological lesions (28% vs. 23%), whereas the non-smoker group exhibited higher rates of chronic cervicitis (23% vs. 16%). However, no statistically significant difference was found between the two groups (p: 0.092). In a comparison of endocervical curettage (ECC) samples, it was observed that the HGSIL, CIS, and AGC-FN rates in the smoker group were almost the same as those in the non-smoker group. However, the LGSIL histopathology results (32% vs. 18%) were higher, and the rate of negativity with no pathology was higher in the non-smoker group (72% vs. 59%). A statistically significant difference in ECC histopathology was noted between the two groups (p &lt; 0.001). An ROC analysis conducted between smoking pack-years and the colposcopic and endocervical curettage biopsy results revealed that the cutoff value for the colposcopic abnormal histopathological results increased, with 40% sensitivity and 76% specificity above 20 pack-years (AUC: 0.592 and p: 0.025). Additionally, the abnormal histopathology rates for endocervical curettage exhibited 81% sensitivity and 32% specificity above 13 pack-years (AUC: 0.586 and p: 0.008). The rate of abnormalities in the colposcopic biopsy results was 2.19 times higher for individuals with over 20 pack-years, and the rate of abnormalities in the ECC results was 2.08 times higher for those with over 13 pack-years; additionally, statistically significant results were obtained (p-values of 0.027 and 0.008, respectively). Conclusions: The most important cause of neoplastic changes in the cervix uteri is high-risk HPV infection, with evidence indicating that prolonged excessive smoking significantly exacerbates the persistence and progression of HPV infection, thereby influencing neoplastic changes in the cervix uteri. It is crucial for women to cease smoking in order to eradicate HPV infection from the body.<\/jats:p>","DOI":"10.3390\/medicina61020235","type":"journal-article","created":{"date-parts":[[2025,1,28]],"date-time":"2025-01-28T06:47:29Z","timestamp":1738046849000},"page":"235","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Impact of Smoking on Cervical Histopathological Changes in High-Risk HPV-Positive Women: A Matched Case\u2013Control Study"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6385-4730","authenticated-orcid":false,"given":"\u0130lkan","family":"Kayar","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Osmaniye State Hospital, 80000 Osmaniye, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1506-6061","authenticated-orcid":false,"given":"Goksu","family":"Goc","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, American Hospital, 10000 Prishtine, Kosovo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8613-2711","authenticated-orcid":false,"given":"Ferhat","family":"Cetin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Private Osmaniye Park Hospital, 80010 Osmaniye, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1939-3743","authenticated-orcid":false,"given":"\u00d6zer","family":"Birge","sequence":"additional","affiliation":[{"name":"Department of Gynecological Oncology, Niger Turkey Friendship Hospital, Niamey G3PR+2JJ, Niger"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3945\/an.116.012211","article-title":"World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015","volume":"7","author":"McGuire","year":"2016","journal-title":"Adv. Nutr."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ferlay, J., Colombet, M., Soerjomataram, I., Parkin, D.M., Pi\u00f1eros, M., Znaor, A., and Bray, F. (Int. J. Cancer, 2021). Cancer statistics for the year 2020: An overview, Int. J. Cancer, ahead of print.","DOI":"10.1002\/ijc.33588"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"21751","DOI":"10.1002\/cam4.6740","article-title":"Evaluation of colposcopy after the addition of human papillomavirus testing to the Turkish cervical cancer screening program","volume":"12","author":"Gunes","year":"2023","journal-title":"Cancer Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Restaino, S., Pellecchia, G., Arcieri, M., Bogani, G., Taliento, C., Greco, P., Driul, L., Chiantera, V., Ercoli, A., and Fanfani, F. (2024). Management for Cervical Cancer Patients: A Comparison of the Guidelines from the International Scientific Societies (ESGO-NCCN-ASCO-AIOM-FIGO-BGCS-SEOM-ESMO-JSGO). Cancers, 16.","DOI":"10.3390\/cancers16142541"},{"key":"ref_5","first-page":"572","article-title":"Assessment of frequency of regression and progression of mild cervical neoplasia--LGSIL in women with positive high-risk HPV DNA test result","volume":"83","author":"Pruski","year":"2012","journal-title":"Ginekol. Pol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vaccine.2006.06.018","article-title":"Chapter 5: Updating the natural history of HPV and anogenital cancer","volume":"24","author":"Moscicki","year":"2006","journal-title":"Vaccine"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/oxfordjournals.aje.a112460","article-title":"Smoking and cancer of the uterine cervix: Hypothesis","volume":"106","author":"Winkelstein","year":"1977","journal-title":"Am. J. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/ijc.21493","article-title":"Carcinoma of the cervix and tobacco smoking: Collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies","volume":"118","author":"Appleby","year":"2006","journal-title":"Int. J. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/jnci\/85.12.958","article-title":"Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia","volume":"85","author":"Schiffman","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1023\/A:1020668232219","article-title":"Clearance of oncogenic human papillomavirus (HPV) infection: Effect of smoking (United States)","volume":"13","author":"Giuliano","year":"2002","journal-title":"Cancer Causes Control"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","article-title":"Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: A systematic analysis of the global literature","volume":"404","author":"Wei","year":"2024","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/ije\/dyn033","article-title":"Smoking and human papillomavirus infection: Pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys","volume":"37","author":"Vaccarella","year":"2008","journal-title":"Int. J. Epidemiol."},{"key":"ref_14","first-page":"125","article-title":"Nicotine and cotinine in the cervical mucus of smokers, passive smokers, and nonsmokers","volume":"1","author":"McCann","year":"1992","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_15","first-page":"295","article-title":"The effect of stopping smoking on cervical Langerhans\u2019 cells and lymphocytes","volume":"108","author":"Szarewski","year":"2001","journal-title":"BJOG"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000292372","article-title":"Tobacco smoking impairs the local immunosurveillance in the uterine cervix. An immunohistochemical study","volume":"39","author":"Poppe","year":"1995","journal-title":"Gynecol. Obs. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1054\/bjoc.2001.1779","article-title":"HPV co-factors related to the development of cervical cancer: Results from a population-based study in Costa Rica","volume":"84","author":"Hildesheim","year":"2001","journal-title":"Br. J. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10654-007-9180-8","article-title":"Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade, C.I.N","volume":"22","author":"Shabalova","year":"2007","journal-title":"Eur. J. Epidemiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.1989.03420110069026","article-title":"Cigarette smoking and exposure to passive smoke are risk factors for cervical cancer","volume":"261","author":"Slattery","year":"1989","journal-title":"JAMA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/01.AOG.0000148268.43584.03","article-title":"Active and passive cigarette smoking and the risk of cervical neoplasia","volume":"105","author":"Trimble","year":"2005","journal-title":"Obs. Gynecol."},{"key":"ref_21","first-page":"349","article-title":"Active and passive cigarette smoke exposure and cervical intraepithelial neoplasia","volume":"1","author":"Coker","year":"1992","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3109\/09513590.2011.558953","article-title":"Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: A review of the literat\u00fcre","volume":"27","author":"Gadducci","year":"2011","journal-title":"Gynecol. Endocrinol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2007\/914823","article-title":"The epidemiology of human papillomavirus infection and cervical cancer","volume":"23","author":"Bosch","year":"2007","journal-title":"Dis. Markers"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1001\/jama.1986.03370230071033","article-title":"Cigarette smoking and invasive cervical cancer","volume":"255","author":"Brinton","year":"1986","journal-title":"J. Am. Med. Assoc."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz, J.P., Carrillo-Beltr\u00e1n, D., Aedo-Aguilera, V., Calaf, G.M., Le\u00f3n, O., Maldonado, E., Tapia, J.C., Boccardo, E., Ozbun, M.A., and Aguayo, F. (2018). Tobacco Exposure Enhances Human Papillomavirus 16 Oncogene Expression via EGFR\/PI3K\/Akt\/c-Jun Signaling Pathway in Cervical Cancer Cells. Front. Microbiol., 9.","DOI":"10.3389\/fmicb.2018.03022"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nri803","article-title":"Effects of cigarette smoke on the immune system","volume":"2","author":"Sopori","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00262-007-0415-z","article-title":"Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells","volume":"57","author":"ElMasri","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/14737140.2021.1888719","article-title":"Is smoking an independent risk factor for developing cervical intra-epithelial neoplasia and cervical cancer? A systematic review and meta-analysis","volume":"21","author":"Nagelhout","year":"2021","journal-title":"Expert. Rev. Anticancer Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/OLQ.0b013e3181a96d0e","article-title":"Acquisition of high-risk human papillomavirus infection in a population-based cohort of Danish women","volume":"36","author":"Nielsen","year":"2009","journal-title":"Sex. Transm. Dis."},{"key":"ref_30","first-page":"421","article-title":"Incidence, clearance and predictors of human papillomavirus infection in women","volume":"168","author":"Sellors","year":"2003","journal-title":"CMAJ"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/clpt.1994.161","article-title":"The importance of measuring cotinine levels to identify smokers in clinical trials","volume":"56","author":"Apseloff","year":"1994","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/14767051003758887","article-title":"Smoking prevalence in early pregnancy: Comparison of self-report and anonymous urine cotinine testing","volume":"24","author":"Swamy","year":"2011","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101793","DOI":"10.1016\/j.canep.2020.101793","article-title":"Exposure to tobacco smoke measured by urinary nicotine metabolites increases risk of p16\/Ki-67 co-expression and high-grade cervical neoplasia in HPV positive women: A two year prospective study","volume":"68","author":"White","year":"2020","journal-title":"Cancer Epidemiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/dc.2840100317","article-title":"DNA adduct assay in cervical epithelium","volume":"10","author":"Simons","year":"1994","journal-title":"Diagn. Cytopathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s00384-014-1922-y","article-title":"The impact of smoking on HPV infection and the development of anogenital warts","volume":"29","author":"Kaderli","year":"2014","journal-title":"Int. J. Color. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1002\/ijc.29971","article-title":"Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study","volume":"138","author":"Skinner","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.3802\/jgo.2017.28.e47","article-title":"Role of active and passive smoking in high-risk human papillomavirus infection and cervical intraepithelial neoplasia grade 2 or worse","volume":"28","author":"Feng","year":"2017","journal-title":"J. Gynecol. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ijc.28666","article-title":"Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort","volume":"135","author":"Roura","year":"2014","journal-title":"Int. J. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0168-1702(02)00188-0","article-title":"Environmental co-factors in HPV carcinogenesis","volume":"89","author":"Bosch","year":"2002","journal-title":"Virus Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2006.05.115","article-title":"Chapter 1: HPV in the etiology of human cancer","volume":"24","author":"Gissmann","year":"2006","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"International Collaboration of Epidemiological Studies of Cervical Cancer (2007). Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: Collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1374 women with adenocarcinoma from 12 epidemiological studies. Int. J. Cancer, 120, 885\u2013891.","DOI":"10.1002\/ijc.22357"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1158\/1055-9965.EPI-11-0284","article-title":"Smoking and passive smoking in cervical cancer risk: Pooled analysis of couples from the IARC multicentric case-control studies","volume":"20","author":"Louie","year":"2011","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2006.11.012","article-title":"Lifetime cigarette smoke and second-hand smoke and cervical intraepithelial neoplasm\u2014A community-based case-control study","volume":"105","author":"Tsai","year":"2007","journal-title":"Gynecol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0361-090X(02)00039-9","article-title":"Active and passive smoking, high-risk human papillomaviruses and cervical neoplasia","volume":"26","author":"Coker","year":"2002","journal-title":"Cancer Detect. Prev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1248\/bpb.b19-01098","article-title":"Evidence of Passive Smoking as a Risk Factor of High-Grade Squamous Intraepithelial Lesion: A Case-Control Study","volume":"43","author":"Du","year":"2020","journal-title":"Biol. Pharm. Bull."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/235\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:37:30Z","timestamp":1759919850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,28]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["medicina61020235"],"URL":"https:\/\/doi.org\/10.3390\/medicina61020235","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,28]]}}}